New CSE Biotech Stock Listing - MindBio Therapeutics Corp. (CSE: MBIO)
May 4, 2023 (Investorideas.com Newswire) The common shares of MindBio Therapeutics Corp. have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the trading date.
MindBio Therapeutics Corp., through its wholly owned subsidiaries, MindBio Therapeutics Pty. Ltd. and Digital Mind Technology Pty Ltd., operates as a biotechnology company focused on creating novel and emerging treatments for mental health conditions. The Company has a notable presence in microdosing of psychedelic medicines and is advancing its drug and technology intervention protocols through clinical trials. The Company invests in research that forms the basis for developing novel and clinically proven treatments including digital technologies and interventions to treat debilitating health conditions such as depression, anxiety and other related mental health conditions.
________________________
Les actions ordinaires de MindBio Therapeutics Corp. ont ete approuvees pour etre cotees sur le CSE.
Les documents d'inscription et d'information seront disponibles sur www.thecse.com a la date de negociation.
MindBio Therapeutics Corp., par l'intermediaire de ses filiales en propriete exclusive, MindBio Therapeutics Pty. Ltd. et Digital Mind Technology Pty Ltd., opere en tant que societe de biotechnologie axee sur la creation de traitements nouveaux et emergents pour les problemes de sante mentale. La societe a une presence notable dans le microdosage des medicaments psychedeliques et fait progresser ses protocoles d'intervention medicamenteux et technologiques par le biais d'essais cliniques. La Societe investit dans la recherche qui constitue la base du developpement de traitements nouveaux et eprouves en clinique, y compris des technologies numeriques et des interventions pour traiter des problemes de sante debilitants tels que la depression, l'anxiete et d'autres problemes de sante mentale connexes.

The Exchange is accepting Market Maker applications for MBIO. Please email: Trading@theCSE.com
If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com
Pour toute question, pour obtenir de l'information supplementaire veuillez communiquer avec le service des inscriptions au 416 367-7340 ou par courriel a l'adresse: Listings@thecse.com
Investorideas.com is a Canadian Securities Exchange (CSE) Service Provider; Cannabis stocks, Blockchain stocks, Mining, E-sports, Energy, Biotech and more...

The Canadian Securities Exchange, or CSE, is operated by CNSX Markets Inc. Recognized as a stock exchange in 2004; the CSE began operations in 2003 to provide a modern and efficient alternative for companies looking to access the Canadian public capital markets. http://thecse.com/
More Info:

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp